Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    Uncategorized Posts

    Virtual Dialogue has 93 Registrations Far Exceeding Expectations

    November 13th, 2020

    In five days, on November 17, at 7:30pm (Eastern Standard Time / New York), the Chondrosarcoma Foundation will host its first Virtual Dialogue: Straight Talk About Chondrosarcoma. We are fortunate to be bringing together a large diverse group…

    Read Article

    Virtual Dialogue has 93 Registrations Far Exceeding Expectations


    In five days, on November 17, at 7:30pm (Eastern Standard Time / New York), the Chondrosarcoma Foundation will host its first Virtual Dialogue: Straight Talk About Chondrosarcoma. We are fortunate to be bringing together a large diverse group…

    Read Article

    Seventy Registrations for Virtual Dialogue: Straight Talk About Chondrosarcoma

    October 30th, 2020

    Read Article

    Results of A Phase 1 Study on Ivosidenib for Patients with Advanced Chondrosarcoma

    October 23rd, 2020

    Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma

    William D. Tap, MD1,2; Victor M. Villalobos, MD, PhD3; Gregory M. Cote, MD, PhD4; Howard Burris, MD5; Filip Janku, MD,…

    Read Article

    Clinical Trial on IDH1 Inhibitor Shows Success in Decreasing Chondrosarcoma Cells

    October 21st, 2020

    Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells

    Luyuan Li,
    Ana C. Paz,
    Breelyn A. Wilky,
    Britt Johnson,
    Karina…

    Read Article

    Invitation to Register for Virtual Dialogue: Straight Talk About Chondrosarcoma

    October 20th, 2020

    Straight Talk About Chondrosarcoma
    A Virtual Dialogue (Via Zoom)
    Tuesday, November 17, 2020
    7:30pm – 8:30pm EST

    www.csfshayna.org/straight-talk-registration/

    Please share and circulate this invitation to all Oncologists and Sarcoma…

    Read Article

    Clinical Research Study by Jonathan Trent on Effectiveness of IDH Inhibitors in Chondrosarcoma

    October 19th, 2020

    The Biology and Management of Cartilaginous Tumors: A Role For Targeting Isocitrate Dehydrogenase

    Gabriel Tinoco, MD, Breelyn A. Wilky, MD, Ana Paz-Mejia, MS, Andrew Rosenberg, MD, Jonathan C. Trent, MD, PhD

    Jonathan Trent, M.D., Ph.D. is a world…

    Read Article

    Medical Book on Sarcoma’s from Jonathan Trent, M.D.

    October 16th, 2020

    Sarcomas: Evidence-Based Diagnosis and Management
    Jonathan C. Trent, Andrew E. Rosenberg, Raphael Pollock, Thomas F. Delaney
    Springer Publishing Company, Incorporated, 2020 – Medical – 434 pages

    Jonathan Trent, M.D.,Ph.D. is the leader of the…

    Read Article

    Invitation to Oncologists and Sarcoma Specialists: Register for Virtual Dialogue: Straight Talk About Chondrosarcoma

    October 15th, 2020

    Straight Talk About Chondrosarcoma

    A Virtual Dialogue (Via Zoom)
    Tuesday, November 17, 2020
    7:30pm – 8:30pm EST

    www.csfshayna.org/straight-talk-registration/

    Please share and circulate this invitation to all Oncologists and Sarcoma…

    Read Article

    Message for the Registrants for Virtual Dialogue: Straight Talk About Chondrosarcoma

    October 12th, 2020

    Straight Talk About Chondrosarcoma
    A Virtual Dialogue (Via Zoom)
    Tuesday, November 17, 2020
    7:30pm – 8:30pm Easter Standard Time

    For CS Warriors who have been newly diagnosed, for CS Warriors that have been diagnosed with a reoccurrence of…

    Read Article